Koers Rock Creek Pharmaceuticals Inc Nasdaq
Aandelen
US7720812046
Farmaceutische producten
Omzet 2014 | - | Omzet 2015 | - | Marktkapitalisatie | 8,21 mln. 7,68 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2014 | -38 mln. -35,58 mln. | Nettowinst (verlies) 2015 | -6 mln. -5,62 mln. | EV/omzet 2014 | - |
Nettoliquiditeiten 2014 | 45K 42,13K | Nettoschuld 2015 | 19,86 mln. 18,59 mln. | EV/omzet 2015 | - |
K/w-verhouding 2014 |
-0,87
x | K/w-verhouding 2015 |
-1,04
x | Werknemers | - |
Dividendrendement 2014 * |
-
| Dividendrendement 2015 |
-
| Vrij verhandelbaar | 100% |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+54,61% | 815 mld. | |
+44,25% | 654 mld. | |
-6,33% | 354 mld. | |
+20,62% | 337 mld. | |
+10,44% | 302 mld. | |
+18,45% | 247 mld. | |
+2,09% | 229 mld. | |
+13,03% | 219 mld. | |
+8,61% | 171 mld. |